Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Khiron Life Sciences Corp (OP: KHRNF )

0.3050 USD -0.0151 (-4.72%)
Official Closing Price Updated: 3:59 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 466,100
Open 0.3168
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.3201
Today's Range 0.3016 - 0.3520
52wk Range 0.2161 - 0.8713
Shares Outstanding 46,852,073
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Khiron CEO to Participate at ATB 9th Annual Institutional Investor Conference
From PR Newswire
Khiron Provides Year-End Corporate Update
From PR Newswire

Performance

YTD
+8.50%
+8.50%
1 Month
+12.17%
+12.17%
3 Month
-13.08%
-13.08%
6 Month
-14.88%
-14.88%
1 Year
-62.13%
-62.13%

More News

Read More
Khiron to Present at the 13th Annual LD Micro Main Event Conference
From PR Newswire
TAAL Announces AGM Results and Senior Management Appointments
From PR Newswire
Khiron Becomes First Company to Export High THC Medical Cannabis From Colombia
From PR Newswire
Khiron Medical Cannabis Products Now Qualify for National Insurance Coverage in Colombia
From PR Newswire
Khiron to Open New Regional Zerenia™ Clinic in Medellin, Colombia
From PR Newswire
Khiron Reports Third Quarter 2020 Financial Results
From PR Newswire
Juan Carlos Echeverry, Former Colombian Minister of Finance and Former CEO of Colombia's Largest Company, Joins Khiron Board of Directors
From PR Newswire
Khiron Plans to Launch Its Zerenia™ Medical Cannabis Clinic Strategy in Mexico; Applauds Mexican Senate Approval of Legislation for Cannabis in Mexico
From PR Newswire
TMX Group, Khiron, C-Suite at The Open
From PR Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.